Human Reproduction, Vol. 17, No. 4, 1067-1071,
April 2002
© 2002 European Society of Human Reproduction and Embryology
Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure
1 Departments of Histopathology and 2 Obstetrics and Gynaecology, Imperial College School of Medicine, St Mary's Hospital, Paddington, London, W2 1PG and 3 Department of Reproductive Pathology, St Mary's Hospital, Manchester, UK
BACKGROUND: Primary antiphospholipid antibody syndrome (PAPS) is an established cause of recurrent pregnancy loss, traditionally presumed to be due to `intraplacental thromboses'. This study examines products of conception (POC) from early pregnancy failures to investigate the mechanism of pregnancy loss. METHODS: POC from patients attending a recurrent miscarriage clinic and from terminations of pregnancy for non-medical reasons were examined histologically with particular regard to the presence or absence of vascular or intervillous thromboses and decidual endovascular trophoblast invasion. RESULTS: There were 31 PAPS–positive, 50 PAPS–negative, 34 aneuploid and 20 control cases at 6–14 weeks gestation. Villous morphology and frequency of intervillous thrombosis were not different among groups. Normal intradecidual endovascular trophoblast invasion was identified significantly less frequently in PAPS+ cases (24%), compared with controls (75%), aneuploid (53%), or PAPS– cases (61%; Z = –3.0, P < 0.01). In all cases there was apparently normal interstitial extravillous trophoblast invasion. CONCLUSIONS: Defective decidual endovascular trophoblast invasion, rather than excessive intervillous thrombosis, is the most frequent histological abnormality in PAPS+ associated early pregnancy loss. Furthermore, endovascular trophoblast invasion is not significantly reduced in the majority of fetal aneuploidy-associated pregnancy failures.
Key words: antiphospholipid antibodies/antiphospholipid antibody syndrome/endovascular trophoblast/pregnancy loss/recurrent miscarriage
4 To whom correspondence should be addressed. E-mail: l.regan{at}ic.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. R. McCrae Tissue factor needs a "complement" Blood, October 1, 2007; 110(7): 2228 - 2228. [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Brosens, P. De Sutter, T. Hamerlynck, L. Imeraj, Z. Yao, B. Cloke, J. J. Brosens, and M. Dhont Endometriosis is associated with a decreased risk of pre-eclampsia Hum. Reprod., June 1, 2007; 22(6): 1725 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Di Simone, P.L. Meroni, M. D'Asta, F. Di Nicuolo, M.C. D'Alessio, and A. Caruso Pathogenic role of anti-{beta}2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin Hum. Reprod. Update, March 1, 2007; 13(2): 189 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jindal, L. Regan, E.O. Fourkala, R. Rai, G. Moore, R.D. Goldin, and N.J. Sebire Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review Hum. Reprod., February 1, 2007; 22(2): 313 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Giannakopoulos, F. Passam, S. Rahgozar, and S. A. Krilis Current concepts on the pathogenesis of the antiphospholipid syndrome Blood, January 15, 2007; 109(2): 422 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Francis, R. Rai, N. J. Sebire, S. El-Gaddal, M. S. Fernandes, P. Jindal, A. Lokugamage, L. Regan, and J. J. Brosens Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome Mol. Hum. Reprod., July 1, 2006; 12(7): 435 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Hills, V. M. Abrahams, B. Gonzalez-Timon, J. Francis, B. Cloke, L. Hinkson, R. Rai, G. Mor, L. Regan, M. Sullivan, et al. Heparin prevents programmed cell death in human trophoblast Mol. Hum. Reprod., April 1, 2006; 12(4): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Shoenfeld and M Blank Autoantibodies associated with reproductive failure Lupus, September 1, 2004; 13(9): 643 - 648. [Abstract] [PDF]
|
|
|
|
|
|
P L Meroni, N di Simone, C Testoni, M D'Asta, B Acaia, and A Caruso Antiphospholipid antibodies as cause of pregnancy loss Lupus, September 1, 2004; 13(9): 649 - 652. [Abstract] [PDF]
|
|
|
|
 |
|
 G. J. Burton and E. Jauniaux Placental Oxidative Stress: From Miscarriage to Preeclampsia Reproductive Sciences, September 1, 2004; 11(6): 342 - 352. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Quenby, S. Mountfield, J. E. Cartwright, G. St. J. Whitley, and G. Vince Effects of Low-Molecular-Weight and Unfractionated Heparin on Trophoblast Function Obstet. Gynecol., August 1, 2004; 104(2): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Robertson, C. T. Roberts, E. v. Beijering, K. Pensa, Y. Sheng, T. Shi, and S. A. Krilis Effect of {beta}2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice Mol. Hum. Reprod., June 1, 2004; 10(6): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Prefumo, N.J. Sebire, and B. Thilaganathan Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices Hum. Reprod., January 1, 2004; 19(1): 206 - 209. [Abstract] [Full Text] [PDF]
|
|